Radiolabeled antibodies in renal cell carcinoma

Renal cell carcinoma (RCC) is a radio- and chemotherapy resistant tumor, which has a very high morbidity and mortality when metastasized. The current treatment options demonstrate limited efficacy and severe side-effects. Therefore, there is a need for new therapeutic strategies for RCC. As for othe...

Descripción completa

Detalles Bibliográficos
Autores principales: Stillebroer, Alexander B., Oosterwijk, Egbert, Oyen, Wim J.G., Mulders, Peter F.A., Boerman, Otto C.
Formato: Texto
Lenguaje:English
Publicado: e-Med 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151324/
https://www.ncbi.nlm.nih.gov/pubmed/18055291
http://dx.doi.org/10.1102/1470-7330.2007.0025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151324/
https://www.ncbi.nlm.nih.gov/pubmed/18055291
http://dx.doi.org/10.1102/1470-7330.2007.0025

Ejemplares similares